Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
2.290
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
2.270
-0.020 (-0.87%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Femasys Market Cap
Femasys has a market cap or net worth of $6.91 million as of August 14, 2026. Its market cap has decreased by -72.30% in one year.
Market Cap
6.91M
Enterprise Value
6.26M
1-Year Change
-72.30%
Ranking
Category
Stock Price
$2.29
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $6.91M, a decrease of -95.48%. That is a compound annual growth rate of -45.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.91M | -79.79% |
| Dec 31, 2025 | 34.22M | 35.85% |
| Dec 31, 2024 | 25.19M | 19.33% |
| Dec 29, 2023 | 21.11M | 98.53% |
| Dec 30, 2022 | 10.63M | -76.90% |
| Dec 31, 2021 | 46.02M | -69.90% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nephros | 50.23M |
| Precision Optics Corporation | 47.99M |
| Milestone Scientific | 43.79M |
| Harvard Bioscience | 30.02M |
| Jin Medical International | 26.46M |
| Retractable Technologies | 20.73M |
| Bionano Genomics | 13.90M |
| Regentis Biomaterials | 10.36M |